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Aims First-phase ejection fraction (EF1), the EF at the time to peak aortic jet velocity, has been proposed as a novel
marker of peak systolic function in aortic stenosis (AS). This study aimed to explore the association of myocardial




Data from a prospective, cross-sectional study of 114 patients with mild, moderate, and severe AS with preserved
left ventricular EF (>50%) were analysed. EF1 was measured as the volume change from end-diastole to the time
that corresponded to peak aortic jet velocity. Myocardial contractility was assessed by strain rate measured by
speckle tracking echocardiography. Arterial stiffness was assessed by central pulse pressure/stroke volume index
ratio (PP/SVi). The total study population included 48% women, median age was 73 years, and mean peak aortic jet
velocity was 3.47 m/s. In univariable linear regression analyses, lower EF1 was associated with higher age, higher
peak aortic jet velocity, lower global EF, lower global longitudinal strain, lower strain rate, and higher PP/SVi. There
was no significant association between EF1 and heart rate or sex. In multivariable linear regression analysis, EF1
was associated with lower strain rate and higher PP/SVi, independent of AS severity. Replacing PP/SVi by valvular
impedance did not change the results.
...................................................................................................................................................................................................
Conclusion In patients with AS, reduced myocardial contractility and increased arterial load were associated with lower EF1 in-
dependent of the severity of valve stenosis.
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Introduction
Aortic stenosis (AS) is the most common cause of aortic valve re-
placement in developed countries.1,2 Once symptoms occur or there
is a reduction in left ventricular ejection fraction (LVEF) <50%, the
current guidelines recommend aortic valve intervention.3,4 The tran-
sition to symptoms partly reflects maladaptive compensatory mecha-
nisms,5 particularly characterized by myocardial fibrosis which may
not reverse following aortic valve replacement.6
Experimental research has suggested that when systolic function is
impaired in early systole an intrinsic mechanism may exist to preserve
LVEF, but at the expense of a slower and sustained contraction.7,8
However, in AS it is well known that LVEF may be preserved by com-
pensatory remodelling and hypertrophy,9 despite reduced myocar-
dial contractility.10 Recently, the first-phase EF (EF1), a measurement
of the LVEF at the time of peak aortic jet velocity, has emerged as a
novel marker of early LV systolic impairment both in hypertension
and AS patients.11,12 Early and accurate recognition of subclinical LV
systolic dysfunction offers the potential to optimize the timing of
intervention in AS. In patients with moderate or severe AS, lower
EF1 showed incremental prognostic value compared with LVEF and
global longitudinal strain.12 However, more information on the
underlying factors influencing EF1 is needed. In particular, the inter-
action between EF1 with myocardial contractility and increased
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arterial load needs further exploration. Increased arterial load is high-
ly prevalent in AS patients due to higher age, hypertension, and large
arterial stiffening. Previous studies have documented the association
of arterial stiffness with impaired myocardial function.13 This study
aimed at exploring the associations between myocardial contractility
and arterial load with EF1 in AS.
Methods
Study population
We prospectively recruited 120 patients with AS from the outpatient
clinic, Department of Heart Disease, Haukeland University Hospital,
Bergen, Norway, between October 2015 and December 2017. Patients
were considered eligible if they had at least mild AS defined as aortic valve
thickening and peak aortic jet velocity >2 m/s. Exclusion criteria were car-
diac arrhythmias, prior pacemaker implantation, other concomitant
valvular disease of more than moderate grade, known coronary artery
disease (myocardial infarction, coronary artery bypass grafting, or percu-
taneous coronary intervention), or previous cardiac surgery. Patients
with reduced LVEF (<50%) (n = 3) were excluded from the present ana-
lysis. The study was approved by the local Regional Committee for
Medical and Health Research Ethics, and was conducted in accordance
with the Declaration of Helsinki. All patients signed a written informed
consent prior to study examinations.
Cardiovascular risk factors
Following inclusion, all participants underwent a clinical examination at
the outpatient clinic. Before the echocardiographic examination, brachial
blood pressure (BP) was measured in triplicate with 1-minute intervals
after an initial 5 minute rest in the seated position using a regularly cali-
brated aneroid sphygmomanometer and appropriate cuff size.14 The
average of the last two measurements was taken as the clinic BP.
Hypertension was defined as use of antihypertensive medication, history
of hypertension, or clinical BP >_140/90 mmHg. Self-reported health was
recorded on a standardized questionnaire including information on car-
diovascular risk factors, medication, and known diseases and was quality
assured by study personnel.
Echocardiography
A standardized transthoracic echocardiogram was performed in all
patients using a Vivid E9 scanner (GE Vingmed Ultrasound, Horten,
Norway). Digital images were stored and analysed at the Bergen
Echocardiographic Core Laboratory using TomTec workstations
equipped with Image Arena 4.6 soft-ware (TomTec, Unterschleissheim,
Germany). Conventional measurements in all studies were first analysed
by the same reader (E.E.) and later proof-read by an experienced reader
(E.G.). Quantitative assessment of the LV and AS severity were per-
formed according to the joint European Association of Echocardiography
and American Society of Echocardiography recommendations.3,15 LV
mass was calculated using the Devereux formula, and indexed to body
height in the allometric power of 2.7 to obtain LV mass index.16 LV
hypertrophy was defined by the prognostically validated cut-off values of
LV mass index >49.2 g/m2.7 in men and LV mass index >46.7 g/m2.7 in
women.16 LVEF was calculated using the Simpson biplane method. Peak
aortic jet velocity was measured from different acoustic windows includ-
ing the use of a stand-alone probe, and the highest velocity was used for
tracing of the time-velocity integral. The effective aortic orifice area was
calculated by the continuity equation. Mild AS was defined as peak aortic
jet velocity of 2.0–2.9 m/s, moderate AS as peak aortic jet velocity of 3.0–
3.9 m/s, and severe AS as peak aortic jet velocity >_4.0 m/s.
Stroke volume (SV) was assessed by Doppler and indexed for body
surface area, as recommended by the guidelines.4 Central pulse pressure
(PP) was estimated using a validated formula: brachial PP 0.49þ age
0.30þ 7.11.17,18 Arterial stiffness was estimated by the ratio from central
PP/SV index (PP/SVi).17 Global LV load was assessed from valvuloarterial
impedance (Zva), calculated as systolic BPþ mean aortic pressure gradi-
ent/SVi.19 Peak systolic annular velocities were measured by tissue
Doppler imaging at the medial and lateral annulus, and averaged to obtain
peak S0.
EF1 was measured by the biplane method of discs by measuring the
volume change from end-diastole to the time that corresponded to peak
aortic jet velocity by spectral Doppler. EF1 was thus derived by:
EF1 ¼ ðEDV  V1Þ
EDV
where EDV is the LV volume at end-diastole and V1 is the LV volume
at the time corresponding to peak aortic jet velocity in the cardiac cycle
(Figure 1).12 EF1 was measured manually at the exact frame of peak aortic
Figure 1 Measurement of first-phase ejection fraction, and its re-
lation with global ejection fraction, global longitudinal strain, and
strain rate.























































jet velocity by taking into account the frame rate and time in milliseconds
from aortic valve opening to peak aortic jet velocity.
Two-dimensional speckle tracking echocardiography and EF1 analyses
were performed offline on a dedicated workstation equipped with
EchoPac BT 202 (GE Vingmed Ultrasound, Horten, Norway), using apical
two-, three-, and four-chamber views with frame rate optimized to 60–
90 frames/s (median 74 frames/s, mean 73 frames/s). The endocardial
border of the LV was traced, and the region of interest was adjusted at
the epicardial border per segment, as appropriate. After software proc-
essing, tracking quality was checked visually, and all segments were
adjusted manually if needed. The time of aortic valve closure was meas-
ured from a pulsed wave Doppler recording in the LV outflow tract, and
was defined as the end of systole. Drift compensation was used during
analysis, and smoothing parameters were kept at default. Global longitu-
dinal strain was calculated as the average peak negative longitudinal short-
ening from the 18 LV segments. Longitudinal strain rate values from the
18 LV segments were averaged to obtain peak systolic strain rate.
Diastolic function was defined in accordance with current guidelines,20
if at least three of the following parameters were present: reduced annular
e0 velocity by tissue Doppler (septal e0 < 7 cm/s or lateral e0 < 10 cm/s);
early transmitral E-wave/average mitral annular velocity ratio (E/e0) >14;
biplane left atrial volume index >34 mL/m2; tricuspid regurgitant jet vel-
ocity >2.8 m/s.
Statistical analyses
Statistical analyses were performed using IBM SPSS version 25.0 (IBM,
Armonk, NY, USA). The study population was divided into three groups:
mild, moderate, and severe AS. Findings are reported as mean ± standard
deviation for continuous variables and as percentages for categorical vari-
ables. Normal distribution was checked prior to analyses by Q–Q plots
and normality tests (Kolmogorov–Smirnov). Groups were compared by
analysis of variance (ANOVA) with Scheffe’s post-hoc test for continuous
variables and by general linear model with Sidak’s post-hoc test for cat-
egorical variables, respectively. Covariates of EF1 were identified in uni-
variable and multivariable linear regression analyses using an enter or
stepwise procedure. The core assumptions of normality of the error dis-
tribution, homoscedasticity, and linearity were tested and not violated.
Multicollinearity was assessed by the variance of inflation factor. Results
are presented as standardized b-coefficients and P values. Goodness of fit
is expressed as the adjusted R2. Independent covariates of EF1 <25%
were tested in univariable and multivariable binary logistics regression
analyses. Results are presented as odds ratio (OR) and 95% confidence
interval (CI). Goodness of fit was tested with Hosmer–Lemeshov’s test.
For intra- and interobserver variability, intraclass correlation coefficients
were calculated to assess agreement between EF1 measurements. Intra-
and interobserver variability of EF1 measurements were assessed in 18
randomly selected subjects by repeated analyses 3 months after initial
reading. A two-tailed P value <0.05 was considered statistically significant
in all analyses.
Results
A total of 120 patients (48% women) were recruited and median age
was 73 years (age range 31–94 years). Six patients were excluded,
three because of suboptimal echocardiographic images, and three
due to reduced LVEF (<50%), leaving 114 patients eligible for the in-
clusion in the present analysis. 16 patients (nine with severe AS and
seven with moderate AS) had mild symptoms. Among those with
symptomatic severe AS, six patients received aortic valve interven-
tion, one patient was offered aortic valve replacement but declined,
while two patients were considered not eligible for valve replace-
ment due to severe comorbidities including cancer. The prevalence
....................................................................................................................................................................................................................
Table 1 Clinical characteristics across patients with mild, moderate, and severe AS
Mild (n ¼ 38) Moderate (n ¼ 44) Severe (n ¼32) P (ANOVA)
Age (years) 72 ± 10 71 ± 12 76 ± 9 0.133
Sex (male) 45% 57% 47% 0.513
Systolic blood pressure (mmHg) 153 ± 25 146 ± 18 143 ± 15 0.063
Diastolic blood pressure (mmHg) 84 ± 11 83 ± 7 79 ± 9* 0.036
Heart rate (bpm) 66 ± 10 68 ± 9 71 ± 12 0.119
Body surface area (m2) 1.89 ± 0.19 1.91 ± 0.24 1.84 ±0.23 0.278
Weight (kg) 78 ± 14 78 ± 18 72 ± 16 0.159
Height (cm) 170 ± 10 171 ± 9 170 ± 9 0.803
Body mass index (kg/m2) 26.9 ± 4.1 26.6 ± 4.6 25.0 ± 3.8 0.066
Hypertension, n (%) 33 (90) 40 (91) 29 (88) 0.912
Diabetes, n (%) 5 (13) 6 (14) 2 (6) 0.563
Current smokers, n (%) 1 (3) 4 (9) 3 (9) 0.109
Symptoms, n (%) 0 (0) 7 (16) 9 (28)* 0.011
NYHA functional class, n (%)
2 0 (0) 6 (14) 8 (25)
3 0 (0) 1 (2) 1 (3)
Hypercholesterolaemia, n (%) 7 (18) 9 (20) 7 (22) 0.938
NYHA, New York Heart Association; bpm, beats per minute.
*P < 0.05 vs. mild AS.































..of hypertension was 89.5%, diabetes 11.4%, hypercholesterolemia
46.5%, and diastolic dysfunction 25.4%. Clinical characteristics be-
tween groups of mild, moderate, and severe AS did not differ, except
for diastolic BP which was lower in patients with severe AS (Table 1).
Patients with severe AS had significantly higher LV mass index and
relative wall thickness (both P < 0.05). Global longitudinal strain,
LVEF, and SVi did not differ between groups (Table 2). Indices of peak
LV systolic function, including acceleration time, strain rate, and EF1
all progressively declined from mild to severe AS (all P < 0.05)
(Table 2 and Figure 2). Filling pressure (E/e0) increased in parallel with
the increasing AS severity grade (P < 0.05).
The intraclass correlation coefficient for EF1 was 0.94 (95% CI
0.85–0.98) for intra-observer variability and 0.88 (95% CI 0.67–0.95)
for interobserver variability, reflecting excellent reproducibility. In
univariable linear regression analyses in the total study population,
lower EF1 was associated with higher LV mass index, older age, and
end-systolic wall stress (Table 3). Lower EF1 was also associated with
lower global longitudinal strain, lower strain rate, and with higher
peak aortic jet velocity. Higher EF1 was associated with a higher peak
S0. In bivariate analyses, EF1 was negatively correlated with higher
Zva (r = -0.33, P < 0.001), PP/SVi (r = -0.29, P = 0.002), higher central
PP (r = -0.29, P = 0.002), higher brachial PP (r = -0.25, P = 0.009), and
with symptoms (r = -0.34, P < 0.001). No association between hyper-
tension and EF1 was detected (P = 0.123). In multivariable linear re-
gression, lower EF1 was associated with lower strain rate
independent of age, peak aortic jet velocity, LV mass index, diastolic
dysfunction, and LVEF (Table 3, Model 1). In Model 2, lower EF1 was
associated with higher PP/SVi independent of age, peak aortic jet vel-
ocity, LVEF, and global longitudinal strain (Table 3). Replacing PP/SVi
by Zva did not change the results. In Model 3, we included all
....................................................................................................................................................................................................................
Table 2 Echocardiographic characteristics across patients with mild, moderate, and severe AS
Mild (n¼38) Moderate (n¼ 44) Severe (n¼ 32) P (ANOVA)
Peak aortic jet velocity (m/s) 2.5 ± 0.3 3.5 ± 0.3* 4.6 ± 0.5** <0.001
Mean aortic gradient (mmHg) 13 ± 3.5 26 ± 4.1* 50 ± 13** <0.001
Aortic valve area (cm2) 1.83 ± 0.34 1.26 ± 0.32* 0.91 ± 0.21** <0.001
Zva (mmHg/mL/m2) 2.9 ± 0.8 3.3 ± 0.9 3.6 ± 0.8* 0.001
LV end-diastolic diameter (mm) 47 ± 6 47 ± 6 45 ± 6 0.246
LV end-systolic diameter (mm) 31 ± 5 31 ± 5 29 ± 5 0.116
Septal wall thickness (mm) 13 ± 2 13 ± 3 16 ± 3** <0.001
Posterior wall thickness (mm) 9 ± 1 10 ± 2 11 ± 2* 0.014
Relative wall thickness 0.41 ± 0.08 0.42 ± 0.09 0.48 ± 0.10** 0.003
LV hypertrophy (%) 34 39 56 0.151
LV mass (g) 195 ± 59 198 ± 65 235 ± 90 0.040
LV mass index (g/m2.7) 46.2 ± 11.9 45.6 ± 11.6 54.8 ± 16.0** 0.006
PP/SVi (mmHg/mL/m2) 1.19 ± 0.29 1.17 ± 0.34 1.20 ± 0.28 0.922
Meridional end-systolic stress (dyne/cm2) 179 ± 37 184 ± 42 192 ± 41 0.376
Systolic function
Global ejection fraction (%) 63 ± 4 62 ± 5 64 ± 5 0.216
Global longitudinal strain (%) -20.5 ± 2.0 -20.0 ± 2.3 -19.1 ± 3.2 0.061
Peak S0 (cm/s) 8.1 ± 1.6 7.8 ± 1.2 7.0 ± 1.2** 0.002
Stroke volume index (mL/m2) 55 ± 10 52 ± 10 55 ± 11 0.319
Global longitudinal strain rate (s-1) -1.05 ± 0.16 -1.03 ± 0.15 -0.94 ± 1.17* 0.017
Mechanical dispersion (ms) 44 ± 12 43 ± 17 57 ± 21** 0.001
First-phase ejection fraction (%) 31 ± 4 30 ± 4 27 ± 4** <0.001
Diastolic function
Filling pressure (E/e0) 11.1 ± 5.5 12.4 ± 5.2 13.9 ± 4.6* 0.010
Peak e0 (cm/s) 6.9 ± 1.6 6.9 ± 1.5 5.7 ± 1.2** <0.001
Tricuspid jet (m/s) 2.47 ± 0.47 2.59 ± 0.33 2.54 ± 0.38 0.460
Left atrial volume index (mL/m2) 33.5 ± 8.5 36.0 ± 12.3 38.9 ± 11.6 0.139
Diastolic dysfunction, n (%) 5 (11) 13 (30) 11 (36)* 0.036
Ejection dynamics
Acceleration time (ms) 78 ± 17 93 ± 18* 111 ± 15** <0.001
Ejection time (ms) 314 ± 31 313 ± 27 323 ± 36 0.353
Acceleration/ejection time ratio 0.25 ± 0.05 0.30 ± 0.05* 0.35 ± 0.05** <0.001
LV, left ventricular; ms; milliseconds; PP/SVi, pulse pressure/stroke volume index; Zva, valvuloarterial impedance.
*P < 0.05 vs. mild AS
**P < 0.05 vs. mild and moderate AS.
































































































significant variables from the univariable analyses in a stepwise pro-
cedure. Lower strain rate, higher peak aortic jet velocity and higher
PP/SVi all remained as significant and independent covariates of EF1
(all P < 0.05) (Table 3). Higher acceleration time was also associated
with lower EF1 in univariable analysis (b = -0.46, P < 0.001). Due to a
strong collinearity between peak aortic jet velocity and acceleration
time, these two variables were not included in the same multivariable
model. However, replacing peak aortic jet velocity with acceleration
time in secondary models, did not change the results, and the as-
sociation between EF1 and acceleration time remained significant
in all multivariable models (data not shown). When restricting
analyses only to moderate and severe AS groups, the association
between PP/SVi and EF1 in multivariable stepwise regression be-
came stronger (b = -0.35, P < 0.001), the association between
peak velocity and EF1 slightly attenuated (b = -0.27, P = 0.006),
while the association between EF1 and strain rate remained
unchanged (b = -0.39, P < 0.001).
In univariable logistic regression analysis, EF1 <25% was associated
with higher mechanical dispersion (OR = 1.03, P = 0.022), but after
multivariable adjustment the association was attenuated (P > 0.05). In
multivariable logistic regression analysis, EF1 <25% shared the same
covariates as for EF1 in a continuous scale (Table 4).
Discussion
The detection of early myocardial dysfunction in AS may be challeng-
ing. After the development of symptoms, there is a sharp increase in
the risk of irreversible myocardial damage and mortality. Irreversible
myocardial damage is often referred to as midwall fibrosis on late
gadolinium enhanced cardiac magnetic resonance imaging, which is
common in AS and reduces the survival benefit of aortic valve
replacement.21 EF1, a measure of peak systolic LV function, has been
shown to predict outcome more precisely than the traditional
markers of end-systolic LV function like LVEF and global longitudinal
strain in patients with AS.12 The present study adds to previous
knowledge by demonstrating that EF1 progressively declined with
increasing AS severity, and that lower EF1 was associated with lower
global longitudinal strain rate and higher PP/SVi independent of AS
severity.
The association between EF1 and strain
rate
Cardiomyocyte contraction occurs predominantly in the first part of
systole and peaks approximately at the time of peak aortic jet vel-
ocity. It has been demonstrated that strain rate and peak aortic jet
velocity are almost simultaneous events in the cardiac cycle,22 and
their respective timing intervals in early systole corresponds well
with peak force development in individual cardiomyocytes.23 In line
with these findings, we observed a closer association between EF1
and peak strain rate than with global longitudinal strain and EF1 in the
present study.
Even though strain rate does not directly measure peak myocardial
contraction per se, the relationship between strain rate and contract-
ility has been shown in an experimental pig model.24 Weidemann
et al. demonstrated that while strain rate was related to contractility,
global longitudinal strain was more closely related to SV and LVEF.25
EF1 and strain rate are measures of peak systolic performance, and
are therefore less load dependent, and more closely related to con-
tractility, which is in line with our findings. In contrast, end-systolic
measures, such as LVEF and global longitudinal strain, are more asso-
ciated with maximal LV load which is reached in late systole. As dem-
onstrated by our results, EF1 showed a progressive reduction from
mild to severe AS while LVEF remained within the normal range
across all grades of AS severity. Similarly, EF1 was also closely related
to peak S0, a reliable marker of systolic function that has been closely
related to contractility.26
Peak systolic indices are also better markers of changes in inotrop-
ic alterations.26 Strain rate often remains constant during an increase
in heart rate, suggesting that it is relatively independent of heart rate
variations.25 Similarly, no correlation between heart rate and EF1 was
detected in this study.
Strain rate has been shown to be affected by both preload and
afterload, but to a lesser degree than end-systolic markers.27 In this
regard, it is inevitable that EF1 to a certain degree is load dependent
due to its close correlation with strain rate. This is reflected by our
findings, as EF1 remained associated with peak strain rate independ-
ent of both PP/SVi and AS severity, together representing the total
arterial- and valvular load on the LV. Thus, lower EF1 is not just a con-
sequence of afterload excess, but reflects impairment in intrinsic
myocardial systolic contractility. These results are in line with previ-
ous research demonstrating that in severe AS patients, the ratio be-
tween wall stress and LVEF is significantly reduced, indicating
reduced contractility.28 This highlights the fact that watchful waiting
for spontaneous symptoms in some patients with severe AS may lead
to irreversible damage in LV myocardium. As recommended by the
guidelines, valve replacement is recommended in patients with
asymptomatic very severe AS (peak jet velocity > 5.5 m/s).3,29 We
Figure 2 Distribution of first-phase ejection fraction (EF1) in sub-
groups of AS.












































hypothesize that EF1 could be particular useful in this setting as a sen-
sitive and prognostically validated tool to guide treatment decisions
in patients with asymptomatic severe AS and normal LVEF in the
future.
The association between EF1 and
arterial stiffness
In AS, increased LV load is caused by combined arterial and valvular
resistance. Increased arterial load in AS is commonly caused by
hypertension and/or increased arterial stiffness.19,30 Interestingly, in
this study higher PP/SVi, a surrogate of arterial stiffness, was identified
as an important covariate of EF1. In patients with arterial stiffness, the
reflected-wave reaches the proximal aorta in early systole, boosting
systolic BP and increasing myocardial oxygen demand.20 Early wave
reflections increase the pulsatile load in mid-systole, and may occur
at the time corresponding to EF1. This underlines the importance of
time-varying systolic load on LV function. The increased tension in
early systole might prolong contraction, preserving LVEF at the ex-
pense of an impaired early systolic function and diastolic relaxation.
We corroborate previous findings by demonstrating a significant uni-
variable relationship between EF1 and filling pressure.11
In our data, EF1 correlated better with the estimated central PP
than with brachial PP. This is in line with previous findings which
showed that central aortic PP was a better predictor of target organ
damage.31 Higher PP/SVi has also been demonstrated as an independ-
ent predictor of cardiovascular events and all-cause mortality in
hypertensive patients.32 Furthermore, one could speculate that the
arterio–ventricular coupling demonstrated in the current study,
could contribute to the observed impaired prognosis in AS patients
with reduced arterial compliance.18
Limitations
This study was small and performed in AS patients with acceptable
image quality, and assessment may be less feasible and reproducible
in patients with poor acoustic windows. In addition, cause–effect rela-
tions cannot be determined due to the cross-sectional study design.
PP/SVi is an echocardiographic surrogate of arterial stiffness. The re-
lationship between EF1 and a more direct and accurate measure of
arterial stiffness, such as the gold standard pulse wave velocity, should
be tested in larger outcome studies in the future.
EF1 was significantly associated with self-reported symptoms.
However, the true prevalence of symptoms in our study cohort may
have been underestimated since a treadmill exercise test was not
.................................... ..................................... ..................................... .....................................
....................................................................................................................................................................................................................
Table 3 Linear regression analyses of covariates of first-phase ejection fraction










Global longitudinal strain rate (s-1) -0.50 <0.001 -0.38 <0.001 -0.40 <0.001
PP/SVi (mmHg/mL/m2) -0.29 0.002 -0.27 0.003 -0.28 <0.001
Peak aortic jet velocity (m/s) -0.41 <0.001 -0.26 0.003 -0.36 <0.001 -0.33 <0.001
Age (years) -0.28 0.003 -0.20 0.021 -0.11 0.241 NS NS
Global ejection fraction (%) 0.18 0.059 0.13 0.106 0.15 0.059 NS NS
Left ventricular mass index (g/m2.7) -0.24 0.011 -0.02 0.833 NS NS
Diastolic dysfunction (yes/no) -0.29 0.002 -0.09 0.284 NS NS
Filling pressure (E/e0) -0.27 0.004 NS NS
Global longitudinal strain (%) -0.40 <0.001 -0.28 0.001 NS NS
Peak S0 (cm/s) 0.46 <0.001 NS NS
End-systolic wall stress (dyne/cm2) -0.26 0.005 NS NS
Acceleration time (ms) -0.46 <0.001 NS NS
Body mass index (kg/m2) 0.18 0.060 NS NS
Heart rate (bpm) -0.07 0.469 NS NS
Hypertension (yes/no) -0.15 0.123 NS NS
Mechanical dispersion (ms) -0.15 0.127 NS NS
Systolic blood pressure (mmHg) -0.15 0.077 NS NS
Zva (mmHg/mL/m2) -0.33 <0.001 NS NS
Relative wall thickness ratio -0.12 0.188 NS NS
Posterior wall thickness (mm) -0.20 0.033 NS NS
Septal wall thickness (mm) -0.21 0.027 NS NS
Acceleration/ejection time ratio -0.38 <0.001 NS NS
Model 1, multiple R2 0.37, P < 0.001; Model 2, multiple R2 0.37, P < 0.001; Model 3, multiple R2 0.40, P < 0.001. Model 1: multivariable model of the association between EF1 and
global longitudinal strain rate. Model 2: multivariable model of the association between EF1,global longitudinal strain and PP/SVi. Model 3: multivariable stepwise regression
model, including all significant variables from univariable analyses.
ms, milliseconds; NS, not significant; bmp, beats per minute; PP/SVi, pulse pressure/stroke volume index; Zva, valvulo-arterial impedance.
































































performed to assess revealed symptoms. In our study, there was
some overlap in EF1 across mild, moderate and severe AS , which
might limit its application in patients with less severe AS. This needs
to be studied in larger studies with less severe AS. Coronary artery
disease is common in AS patients. Although known coronary artery
disease was an exclusion criterion by design, we cannot exclude that
asymptomatic coronary artery disease may have been present in
some participants with reduced EF1. In severe AS, higher serum B-
type natriuretic peptide has been independently associated with
lower global longitudinal strain.33 However, B-type natriuretic pep-
tide was not measured in the present study, and the relation to EF1
could therefore not be assessed. Lastly, both EF1 and strain rate val-
ues were derived from the B-mode frame rate. This could lead to
inaccuracies in the measurement of EF1 and underestimation of strain
rate. However, we have carefully optimized the frame rate and
achieved an acceptable frame rate which is above the recommended
frame rate threshold for strain rate measurements.
Conclusions
In patients with varying degree of AS, severity, lower myocardial con-
tractility and higher arterial stiffness were both associated with lower
EF1, a marker of peak systolic function, independent of AS severity.
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